Biohit Oyj - Changes board/management/auditors

Changes to Biohit Oyj’s management

Biohit Oyj Stock Exchange Release August 29, 2014 at 2:00 p.m. local time (EEST)


M.Sc. (Tech.), MBA Annika Astola (b. 1974) has been appointed as Quality
Director and a member of the Management Team of Biohit Oyj starting August 29,
2014. She has been Quality Manager at Biohit since April 14, 2014. Before
Biohit Annika Astola has been Quality and Development Manager at Orion
Diagnostica Oy and worked in quality managerial positions at Biovian Oy and Oy
Leiras Finland Ab. 

Lea Paloheimo, previously responsible for Quality in Management Team, continues
as Business Development Director and a member of the Management Team. Both
Annika Astola and Lea Paloheimo report to CEO Semi Korpela. 


Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com


Biohit Oyj in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's
mission ‘Innovating for Health' means that we provide innovative products and
services to promote research and early diagnostics. Biohit is headquartered in
Helsinki and has subsidiaries in Italy and the UK. Biohit's B series shares
(BIOBV) are quoted on NASDAQ OMX Helsinki under Small cap/Healthcare.
www.biohithealthcare.com